GOOGL
62
6
BIIB
36
8
QRVO
16
-6
AIV
39
6
ADBE
50
3
CA
19
6
MS
64
3
UPS
51
6
WHR
61
3
MAS
46
3
PPL
44
9
CTAS
36
8
EQIX
59
2
EA
41
3
TXN
29
4
ZBH
69
15
RRC
52
2
CVX
25
14
EMC
30
-26
CCL
68
6
GOOGL
62
6
BIIB
36
8
QRVO
16
-6
AIV
39
6
ADBE
50
3
CA
19
6
MS
64
3
UPS
51
6
WHR
61
3
MAS
46
3
PPL
44
9
CTAS
36
8
EQIX
59
2
EA
41
3
TXN
29
4
ZBH
69
15
RRC
52
2
CVX
25
14
EMC
30
-26
CCL
68
6
Financhill
Back

Chicago Atlantic Real Estate Finance Vs. Novo Nordisk AS Industry Stock Comparison

Sell
35

REFI
Chicago Atlantic Real Estate Finance

Last Price:
$15.98
Seasonality Move:
-3.38%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
35
Chicago Atlantic Real Estate Finance (REFI) is a Sell

Is Chicago Atlantic Real Estate Finance a Buy, Sell or Hold?

  • The current Chicago Atlantic Real Estate Finance [REFI] share price is $15.98. The Score for REFI is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • REFI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REFI Stock Price Chart

What is Chicago Atlantic Real Estate Finance's stock price today?

  • The Chicago Atlantic Real Estate Finance share price today is $15.98
    The current trend is relatively stagnant and REFI is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

REFI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 50.8 Buy
Chaikin Money Flow: 165294 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.88 - 16.18) Sell
Bollinger Bands (100): (15.36 - 16.02) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

REFI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.03 Sell
20-day SMA: 16.08 Sell
50-day SMA: 15.75 Buy
200-day SMA: 15.71 Buy
8-day EMA: 15.99 Sell
20-day EMA: 15.99 Sell
50-day EMA: 15.85 Buy
200-day EMA: 15.69 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Chicago Atlantic Real Estate Finance Earnings Growth & REFI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.08 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.

Chicago Atlantic Real Estate Finance Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):